Literature DB >> 12834112

Reelin and disabled-1 expression in developing and mature human cortical neurons.

Kimiko Deguchi1, Ken Inoue, William E Avila, Dolores Lopez-Terrada, Barbara A Antalffy, Carlo C Quattrocchi, Michael Sheldon, Katsuhiko Mikoshiba, Gabriella D'Arcangelo, Dawna L Armstrong.   

Abstract

In developing mammalian (mouse) brain, Reelin (Reln) is secreted by the Cajal-Retzius (CR) neurons in the marginal zone, binds apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (Vldlr), and induces the phosphorylation of the downstream cytoplasmic molecule disabled-1 (Dab1) in cortical plate neurons. Although this is a well-characterized signaling pathway in mice, it has not been well defined in human brain. In this paper we examined the expression of RELN, APOER2, VLDLR, and DAB1 in the developing human brain by RT-PCR. We further determined the cellular expression of the proteins RELN and DAB1 in 50 human brains ranging in age from 10 gestational weeks (GW) to 62 years using immunochemistry. We found that the pattern of expression of RELN and DAB1 in the human brain isnot identical to that observed in the mouse brain. In particular, we report the novel finding that human DAB1and RELN are coexpressed in CR neurons during cortical development and in cortical pyramidal neurons after neuronal migration is complete. Thus, in the human brain, the whole RELN signaling pathway is present within selected populations of cortical neurons throughout life. We speculate that RELN and DAB1 coexpression in these neurons is necessary for both normal cortical development and mature function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834112     DOI: 10.1093/jnen/62.6.676

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  20 in total

1.  Embryonic and early postnatal abnormalities contributing to the development of hippocampal malformations in a rodent model of dysplasia.

Authors:  Mercedes Paredes; Samuel J Pleasure; Scott C Baraban
Journal:  J Comp Neurol       Date:  2006-03-01       Impact factor: 3.215

Review 2.  Early pharmacological treatment of autism: a rationale for developmental treatment.

Authors:  Terrence C Bethea; Linmarie Sikich
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

3.  ApoE is required for maintenance of the dentate gyrus neural progenitor pool.

Authors:  Cui-Ping Yang; Jennifer A Gilley; Gui Zhang; Steven G Kernie
Journal:  Development       Date:  2011-08-31       Impact factor: 6.868

4.  RELN-expressing neuron density in layer I of the superior temporal lobe is similar in human brains with autism and in age-matched controls.

Authors:  Jasmin Camacho; Ehsan Ejaz; Jeanelle Ariza; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  Neurosci Lett       Date:  2014-07-25       Impact factor: 3.046

5.  Reelin-mediated Signaling during Normal and Pathological Forms of Aging.

Authors:  Jana Doehner; Irene Knuesel
Journal:  Aging Dis       Date:  2010-06-04       Impact factor: 6.745

6.  Variations of very low-density lipoprotein receptor subtype expression in gastrointestinal adenocarcinoma cells with various differentiations.

Authors:  Tao Chen; Fan Wu; Feng-Ming Chen; Jun Tian; Shen Qu
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

7.  Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Douglas G Walker; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine Hulette; Donald Schmechel; Gene E Alexander; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Physiol Genomics       Date:  2006-10-31       Impact factor: 3.107

8.  Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity.

Authors:  Uwe Beffert; Andre Durudas; Edwin J Weeber; Peggy C Stolt; Klaus M Giehl; J David Sweatt; Robert E Hammer; Joachim Herz
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

9.  A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins.

Authors:  Keiko Sakai; Oliver Tiebel; M Cecilia Ljungberg; Merry Sullivan; Hye-Jeong Lee; Tomoya Terashima; Rongying Li; Kunihisa Kobayashi; Hui-Chen Lu; Lawrence Chan; Kazuhiro Oka
Journal:  Brain Res       Date:  2009-04-22       Impact factor: 3.252

10.  Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?

Authors:  Ryuki Hirano; Heidrun Interthal; Cheng Huang; Tomonori Nakamura; Kimiko Deguchi; Kunho Choi; Meenakshi B Bhattacharjee; Kimiyoshi Arimura; Fujio Umehara; Shuji Izumo; Jennifer L Northrop; Mustafa A M Salih; Ken Inoue; Dawna L Armstrong; James J Champoux; Hiroshi Takashima; Cornelius F Boerkoel
Journal:  EMBO J       Date:  2007-10-18       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.